Ovarian carcinoma cells and IL-1β-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
Ovarian carcinoma and IL-1β-activated peritoneal mesothelial cells are key sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveInflammatory or malignant peritoneal diseases are associated with high levels of ascitic vascular endothelial growth factor (VEGF). We compared the VEGF secretion by human peritoneal mesothelial cells (HPMC) and ovarian carcinoma (OVCA) cells and its regulation by pro-inflammatory cytokines.Materials and methodsVEGF secretion in cultured HPMC, established human OVCA cell lines, and inflammatory or OVCA-associated ascites was determined by enzyme linked immunosorbent assay.ResultsHPMC constitutively produced VEGF at median levels of 43 +/- 7 pg/10(5) cells. Treatment of HPMC with 1 ng/ml IL-1beta (567 +/- 213 pg/10(5) cells) or TNF-alpha (89 +/- 1 pg/10(5) cells) resulted in a 13-fold (P < 0.01) or 2-fold (P < 0.05) elevation of the VEGF secretion. In OVCA, the constitutive VEGF expression was 8-fold higher than VEGF levels in HPMC (364 +/- 185 pg/10(5) cells; P < 0.001). VEGF secretion in OVCA cells was also increased by IL-1beta (514 +/- 105 pg/10(5) cells; P < 0.01) or TNF-alpha (458 +/- 168 pg/10(5) cells; P < 0.01) reaching similar levels as in IL-1beta-activated HPMC. Median VEGF levels in malignant ascites (2761 +/- 1549 pg/ml) were 11-fold higher compared with levels in inflammatory fluids (244 +/- 170 pg/ml; P < 0.01). VEGF levels in both inflammatory- and OVCA-associated fluids correlated with ascitic IL-1beta levels (P < 0.05).ConclusionWe identified ovarian cancer cells and/or IL-1beta-activated peritoneal mesothelial cells as important sources of ascitic VEGF. The present data indicate that IL-1beta-triggered VEGF production by neoplastic and normal cells is a common pathomechanism for ascites formation in both inflammatory and malignant conditions.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (1)
References (48)
- The Role of Angiogenesis in the Accumulation of Peritoneal Fluid in Benign Conditions and the Development of Malignant Ascites in the Female via openalex
- W6677664202 via openalex
- W6679177944 via openalex
- W6716863728 via openalex
- doi:10.1016/s0002-9440(10)65601-5 via openalex
- doi:10.1002/(sici)1097-0142(19990101)85:1<178::aid-cncr25>3.0.co;2-7 via openalex
- doi:10.1002/1097-0142(19931015)72:8<2433::aid-cncr2820720822>3.0.co;2-l via openalex
- doi:10.1038/ki.1993.36 via openalex
- doi:10.1007/s11912-999-0011-9 via openalex
- doi:10.1016/s0002-9440(10)65516-2 via openalex
- doi:10.1023/a:1010645302750 via openalex
- doi:10.1002/hep.510290416 via openalex
- doi:10.1111/j.1440-1827.1995.tb03387.x via openalex
- doi:10.1016/s0304-3835(97)00350-9 via openalex
- doi:10.1006/cyto.1997.0297 via openalex
- doi:10.1046/j.1523-1755.2002.00143.x via openalex
- doi:10.1016/s0022-4804(03)00307-x via openalex
- W32167704 via openalex
- W44660800 via openalex
- doi:10.1111/j.1349-7006.1996.tb02127.x via openalex
- W267870178 via openalex
- W1533193121 via openalex
- W1618719924 via openalex
- W1903437307 via openalex
- doi:10.1007/s10434-999-0373-0 via openalex
- doi:10.1016/s0002-9440(10)65669-6 via openalex
- doi:10.1038/sj.bjc.6600701 via openalex
- doi:10.3748/wjg.v9.i11.2596 via openalex
- doi:10.1016/s0303-7207(01)00709-2 via openalex
- W2119657746 via openalex
- W2131314619 via openalex
- W2417869717 via openalex
- W6601308383 via openalex
- W6601822182 via openalex
- W6609968699 via openalex
- W6636184439 via openalex
- doi:10.1038/bjc.1997.537 via openalex
- doi:10.1006/gyno.2001.6467 via openalex
- doi:10.1007/bf01789047 via openalex
- doi:10.1111/j.1349-7006.2002.tb01302.x via openalex
- doi:10.1177/089686080102103s63 via openalex
- doi:10.1006/cyto.1995.0073 via openalex
- doi:10.1073/pnas.90.19.8915 via openalex
- doi:10.1111/j.1048-891x.2004.14202.x via openalex
- doi:10.1002/(sici)1097-0142(19970701)80:1<98::aid-cncr13>3.0.co;2-a via openalex
- doi:10.1093/jnci/87.7.506 via openalex
- W6639920323 via openalex
- doi:10.1200/jco.1998.16.5.1861 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T05:42:58.953575+00:00
License: CC0
· commercial use OK